Cargando…
Biomarker-estimated flavan-3-ol intake is associated with lower blood pressure in cross-sectional analysis in EPIC Norfolk
Flavan-3-ols are a group of bioactive compounds that have been shown to improve vascular function in intervention studies. They are therefore of great interest for the development of dietary recommendation for the prevention of cardio-vascular diseases. However, there are currently no reliable data...
Autores principales: | Ottaviani, Javier I., Britten, Abigail, Lucarelli, Debora, Luben, Robert, Mulligan, Angela A., Lentjes, Marleen A., Fong, Reedmond, Gray, Nicola, Grace, Philip B., Mawson, Deborah H., Tym, Amy, Wierzbicki, Antonia, Forouhi, Nita G., Khaw, Kay-Tee, Schroeter, Hagen, Kuhnle, Gunter G. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578063/ https://www.ncbi.nlm.nih.gov/pubmed/33087825 http://dx.doi.org/10.1038/s41598-020-74863-7 |
Ejemplares similares
-
Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)
por: Vogiatzoglou, Anna, et al.
Publicado: (2015) -
Evaluation of (−)-epicatechin metabolites as recovery biomarker of dietary flavan-3-ol intake
por: Ottaviani, Javier I., et al.
Publicado: (2019) -
Evaluation at scale of microbiome-derived metabolites as biomarker of flavan-3-ol intake in epidemiological studies
por: Ottaviani, Javier I., et al.
Publicado: (2018) -
Alcohol consumption and future hospital usage: The EPIC-Norfolk prospective population study
por: Luben, Robert, et al.
Publicado: (2018) -
Weight change and 15 year mortality: results from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) cohort study
por: Mulligan, Angela A., et al.
Publicado: (2017)